Trial intelligence / Profile preview

Ventolin plus hypertonic saline versus Ventolin alone for pediatric bronchiolitis

IRCT20180119038433N2Phase 3Completed

Sponsor
Semnan University of Medical Sciences
Start
Feb 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, open-label trial of salbutamol and hypertonic saline in bronchiolitis (2 arms), sponsored by Semnan University of Medical Sciences. Primary endpoints: Duration of hospitalization, Duration of respiratory distress symptoms and 1 more. Started Feb 2020; status: completed.

02

Drugs

salbutamolhypertonic saline
03

Conditions

bronchiolitis

Beyond the preview

Go deeper on IRCT20180119038433N2.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20180119038433N2.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call